Clinical Trial Update: Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative TPF chemotherapy in molecularly selected locally advanced resectable oral cavity squamous cell cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cavity Squamous Cell Carcinoma
• Squamous Cell Carcinoma of the Oral Cavity

Drugs mentioned

• TPF chemotherapy (docetaxel, cisplatin, 5-fluorouracil)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Locally Advanced Resectable Oral Cavity Squamous Cell Cancer | Phase 2 | Status: COMPLETED